CorVel
Manages insurance claims and medical costs through patient management and network solutions.
Something off on this page? Send us feedback.
Profile
Provides claims administration and medical cost-containment services to insurers, employers, administrators, and government payors across the United States. Most revenue comes from patient management, with the rest from network solutions spanning bill review, provider access, pharmacy, directed care, and related services, all reported within one managed-care segment.
Provides medical cost-containment and managed-care services to insurers, third-party administrators, government entities, and self-administered employers across the United States. Patient management—the larger revenue line—covers claims administration, case management, nurse triage, utilization management, vocational rehabilitation, and disability services. Network solutions include medical bill review, preferred-provider networks, pharmacy, Medicare, independent examinations, and CareIQ-directed care.
Combines local claims teams, a national provider network, and proprietary CareMC software in integrated programs, standalone services, or workflow add-ons. Revenue comes from one managed-care segment serving workers’ compensation, automobile, group-health, and other liability programs. Demand depends on claim volumes and customer outsourcing, while bill-review and rehabilitation work is shaped by state fee schedules, licensing rules, and workers’ compensation laws.
Company facts
Key statistics
Year to date +5.3% · Average volume (30d) 164.9K
Analysts
No analyst consensus on record.
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026Q1 FY27 | — | $0.63 | — | — | $259.9M | — | +5.87% |
| May 20, 2026Q4 FY26 | — | $0.61 | — | — | $248.5M | — | −4.23% |
| Feb 3, 2026Q3 FY26 | — | $0.47 | — | — | $235.6M | — | −4.85% |
| Nov 4, 2025Q2 FY26 | — | $0.54 | — | — | $239.6M | — | −0.78% |
Financial highlights
| 12 quarters | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|---|---|---|
| Revenue | $231.5M | $234.7M | $239.6M | $235.6M | $248.5M | $259.9M | |
| Gross profit | $58.0M | $56.8M | $58.2M | $54.9M | $63.0M | $59.0M | |
| Operating income | $33.3M | $35.3M | $35.9M | $32.2M | $39.7M | $43.3M | |
| Net income | $26.4M | $27.2M | $27.9M | $24.2M | $31.0M | $32.2M | |
| Diluted EPS | $0.51 | $0.52 | $0.54 | $0.47 | $0.61 | $0.63 | |
| Gross margin | 25.0% | 24.2% | 24.3% | 23.3% | 25.4% | 22.7% | |
| Operating margin | 14.4% | 15.0% | 15.0% | 13.7% | 16.0% | 16.7% |
Fiscal years (4-quarter sums)FY22 $646.2M · FY23 $718.6M · FY24 $795.3M · FY25 $895.6M · FY26 $958.5M
Revenue by product · Q1 FY27
Balance sheet, Jun 30, 2026Cash & short-term investments $255.9M · Total debt $28.4M · Total assets $689.7M · Shareholders' equity $408.9M
Dividends
No dividends on record.
Ownership
Shares outstanding 51.01M · Float 30.93M · 60.6% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Corstar Holdings Inc · 10 percent owner | 18.74M | 36.74% | Form 4 | Sep 10, 2025 |
| BlackRock, Inc. | 5.14M | 10.08% | 13F | Aug 7, 2026 |
| Kayne Anderson Rudnick Investment Management LLC | 4.55M | 8.92% | 13F | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 1.72M | 3.37% | 13F | Aug 13, 2026 |
| Renaissance Technologies LLC | 1.53M | 3.00% | 13F | Aug 13, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 27, 2026 | R. Judd Jessup | director | −1,262 | $70.64 |
| Aug 26, 2026 | R. Judd Jessup | director | −1,562 | $70.71 |
| Aug 20, 2026 | Jennifer Yoss | officer: Vice President of Accounting | −2,100 | $70.92 |
| Jun 12, 2026 | Maxim Shishin | officer: Chief Information Officer | −2,250 | $60.59 |
| Jun 12, 2026 | Michael G. Combs | officer: CEO & President | −500 | $60.79 |
Peers
- Arthur J. Gallagher
Claims-administration and workers' comp TPA overlap
- Chubb
Claims TPA, managed-care, and risk-control overlap via ESIS
- UnitedHealth Group
Bill review, pharmacy, PPO, and ancillary-care overlap
- Old Republic International
Workers' comp TPA and cost-containment overlap via PMA
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| CorVel | $69.24 | −0.01% | $3.53B | 30.8 | — | 3.6 | +10.7% |
| Arthur J. Gallagher | $250.73 | −6.27% | $68.74B | 44.3 | 19.0 | 4.4 | +22.8% |
| Chubb | $340.37 | +0.13% | $131.14B | 12.0 | 12.2 | 2.1 | −1.3% |
| UnitedHealth Group | $392.50 | −0.12% | $356.86B | 25.3 | 18.4 | 0.8 | +0.4% |
| Old Republic International | $42.07 | 0.00% | $10.25B | 9.2 | 13.1 | 1.1 | +13.4% |
| Median | 18.6 | 15.8 | 1.6 | +6.9% |